Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia

Leah H. Rubin, C. Sue Carter, Lauren L. Drogos, Hossein Pournajafi-Nazarloo, John A. Sweeney, Pauline M. Maki

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

BACKGROUND: In women with schizophrenia, cognition has been shown to be enhanced following administration of hormone therapy or oxytocin. We examined how natural hormonal changes across the menstrual cycle influence cognition in women with schizophrenia. We hypothesized that female patients would perform worse on "female-dominant" tasks (verbal memory/fluency) and better on "male-dominant" tasks (visuospatial) during the early follicular phase (low estradiol and progesterone) compared to midluteal phase (high estradiol and progesterone) in relation to estradiol but not progesterone. METHODS: Fifty-four women (23 with schizophrenia) completed cognitive assessments and provided blood for sex steroid assays and oxytocin at early follicular (days 2-4) and midluteal (days 20-22) phases. Men were included to verify the expected pattern of sex differences on cognitive tests. RESULTS: Expected sex differences were observed on "female-dominant" and "male-dominant" tasks (p <0.001), but the magnitude of those differences did not differ between patients and controls (p=0.44). Cognitive performance did not change across the menstrual cycle on "female-dominant" or "male-dominant" tasks in either group. Estradiol and progesterone levels were unrelated to cognitive performance. Oxytocin levels did not change across the menstrual cycle but were positively related to performance on "female-dominant" tasks in female patients only (p <0.05). CONCLUSIONS: Sex differences in cognitive function are preserved in schizophrenia. Oxytocin levels do not change across the cycle, but relate to enhanced performance on female dominant tests in women. Physiological levels of oxytocin may thus have a more powerful benefit in some cognitive domains than estrogens in schizophrenia.

Original languageEnglish (US)
Pages (from-to)269-275
Number of pages7
JournalSchizophrenia Research
Volume166
Issue number1-3
DOIs
StatePublished - 2015

Fingerprint

Menstrual Cycle
Cognition
Schizophrenia
Oxytocin
Hormones
Progesterone
Estradiol
Sex Characteristics
Follicular Phase
Estrogens
Steroids

Keywords

  • Cognition
  • Estrogen
  • Menstrual cycle
  • Oxytocin
  • Schizophrenia
  • Sex differences

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Rubin, L. H., Carter, C. S., Drogos, L. L., Pournajafi-Nazarloo, H., Sweeney, J. A., & Maki, P. M. (2015). Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia. Schizophrenia Research, 166(1-3), 269-275. https://doi.org/10.1016/j.schres.2015.04.039

Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia. / Rubin, Leah H.; Carter, C. Sue; Drogos, Lauren L.; Pournajafi-Nazarloo, Hossein; Sweeney, John A.; Maki, Pauline M.

In: Schizophrenia Research, Vol. 166, No. 1-3, 2015, p. 269-275.

Research output: Contribution to journalArticle

Rubin, LH, Carter, CS, Drogos, LL, Pournajafi-Nazarloo, H, Sweeney, JA & Maki, PM 2015, 'Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia', Schizophrenia Research, vol. 166, no. 1-3, pp. 269-275. https://doi.org/10.1016/j.schres.2015.04.039
Rubin, Leah H. ; Carter, C. Sue ; Drogos, Lauren L. ; Pournajafi-Nazarloo, Hossein ; Sweeney, John A. ; Maki, Pauline M. / Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia. In: Schizophrenia Research. 2015 ; Vol. 166, No. 1-3. pp. 269-275.
@article{2deca17d9359448dbabe8dc6e3a080c5,
title = "Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia",
abstract = "BACKGROUND: In women with schizophrenia, cognition has been shown to be enhanced following administration of hormone therapy or oxytocin. We examined how natural hormonal changes across the menstrual cycle influence cognition in women with schizophrenia. We hypothesized that female patients would perform worse on {"}female-dominant{"} tasks (verbal memory/fluency) and better on {"}male-dominant{"} tasks (visuospatial) during the early follicular phase (low estradiol and progesterone) compared to midluteal phase (high estradiol and progesterone) in relation to estradiol but not progesterone. METHODS: Fifty-four women (23 with schizophrenia) completed cognitive assessments and provided blood for sex steroid assays and oxytocin at early follicular (days 2-4) and midluteal (days 20-22) phases. Men were included to verify the expected pattern of sex differences on cognitive tests. RESULTS: Expected sex differences were observed on {"}female-dominant{"} and {"}male-dominant{"} tasks (p <0.001), but the magnitude of those differences did not differ between patients and controls (p=0.44). Cognitive performance did not change across the menstrual cycle on {"}female-dominant{"} or {"}male-dominant{"} tasks in either group. Estradiol and progesterone levels were unrelated to cognitive performance. Oxytocin levels did not change across the menstrual cycle but were positively related to performance on {"}female-dominant{"} tasks in female patients only (p <0.05). CONCLUSIONS: Sex differences in cognitive function are preserved in schizophrenia. Oxytocin levels do not change across the cycle, but relate to enhanced performance on female dominant tests in women. Physiological levels of oxytocin may thus have a more powerful benefit in some cognitive domains than estrogens in schizophrenia.",
keywords = "Cognition, Estrogen, Menstrual cycle, Oxytocin, Schizophrenia, Sex differences",
author = "Rubin, {Leah H.} and Carter, {C. Sue} and Drogos, {Lauren L.} and Hossein Pournajafi-Nazarloo and Sweeney, {John A.} and Maki, {Pauline M.}",
year = "2015",
doi = "10.1016/j.schres.2015.04.039",
language = "English (US)",
volume = "166",
pages = "269--275",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia

AU - Rubin, Leah H.

AU - Carter, C. Sue

AU - Drogos, Lauren L.

AU - Pournajafi-Nazarloo, Hossein

AU - Sweeney, John A.

AU - Maki, Pauline M.

PY - 2015

Y1 - 2015

N2 - BACKGROUND: In women with schizophrenia, cognition has been shown to be enhanced following administration of hormone therapy or oxytocin. We examined how natural hormonal changes across the menstrual cycle influence cognition in women with schizophrenia. We hypothesized that female patients would perform worse on "female-dominant" tasks (verbal memory/fluency) and better on "male-dominant" tasks (visuospatial) during the early follicular phase (low estradiol and progesterone) compared to midluteal phase (high estradiol and progesterone) in relation to estradiol but not progesterone. METHODS: Fifty-four women (23 with schizophrenia) completed cognitive assessments and provided blood for sex steroid assays and oxytocin at early follicular (days 2-4) and midluteal (days 20-22) phases. Men were included to verify the expected pattern of sex differences on cognitive tests. RESULTS: Expected sex differences were observed on "female-dominant" and "male-dominant" tasks (p <0.001), but the magnitude of those differences did not differ between patients and controls (p=0.44). Cognitive performance did not change across the menstrual cycle on "female-dominant" or "male-dominant" tasks in either group. Estradiol and progesterone levels were unrelated to cognitive performance. Oxytocin levels did not change across the menstrual cycle but were positively related to performance on "female-dominant" tasks in female patients only (p <0.05). CONCLUSIONS: Sex differences in cognitive function are preserved in schizophrenia. Oxytocin levels do not change across the cycle, but relate to enhanced performance on female dominant tests in women. Physiological levels of oxytocin may thus have a more powerful benefit in some cognitive domains than estrogens in schizophrenia.

AB - BACKGROUND: In women with schizophrenia, cognition has been shown to be enhanced following administration of hormone therapy or oxytocin. We examined how natural hormonal changes across the menstrual cycle influence cognition in women with schizophrenia. We hypothesized that female patients would perform worse on "female-dominant" tasks (verbal memory/fluency) and better on "male-dominant" tasks (visuospatial) during the early follicular phase (low estradiol and progesterone) compared to midluteal phase (high estradiol and progesterone) in relation to estradiol but not progesterone. METHODS: Fifty-four women (23 with schizophrenia) completed cognitive assessments and provided blood for sex steroid assays and oxytocin at early follicular (days 2-4) and midluteal (days 20-22) phases. Men were included to verify the expected pattern of sex differences on cognitive tests. RESULTS: Expected sex differences were observed on "female-dominant" and "male-dominant" tasks (p <0.001), but the magnitude of those differences did not differ between patients and controls (p=0.44). Cognitive performance did not change across the menstrual cycle on "female-dominant" or "male-dominant" tasks in either group. Estradiol and progesterone levels were unrelated to cognitive performance. Oxytocin levels did not change across the menstrual cycle but were positively related to performance on "female-dominant" tasks in female patients only (p <0.05). CONCLUSIONS: Sex differences in cognitive function are preserved in schizophrenia. Oxytocin levels do not change across the cycle, but relate to enhanced performance on female dominant tests in women. Physiological levels of oxytocin may thus have a more powerful benefit in some cognitive domains than estrogens in schizophrenia.

KW - Cognition

KW - Estrogen

KW - Menstrual cycle

KW - Oxytocin

KW - Schizophrenia

KW - Sex differences

UR - http://www.scopus.com/inward/record.url?scp=84940444863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940444863&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2015.04.039

DO - 10.1016/j.schres.2015.04.039

M3 - Article

C2 - 25990704

AN - SCOPUS:84940444863

VL - 166

SP - 269

EP - 275

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -